Neurotrophic Factor GDF5 - an alternative to GDNF?
Neurotrophic factors are small protein that are naturally produced in the brain to help nurture and protect nerve cells (neurons). Cure Parkinson's is a strong supporter of research exploring neurotrophic factors as a future therapeutic strategy for Parkinson's.
Learn more
The 2021 International Linked Clinical Trials Meeting
The International Linked Clinical Trials (iLCT) programme is the flagship drug repurposing initiative of Cure Parkinson’s and Van Andel Institute (VAI) focussed on identifying and clinically testing already available drugs that show potential to slow, stop or reverse the progression of Parkinson’s. Every year the iLCT…
Grand Challenges in Parkinson’s Disease: ‘GBA1 and LRRK2 – from genetic risk to the clinic’
The Van Andel Institute (VAI) in Grand Rapids, Michigan annually hosts this scientific conference ‘Grand Challenges in Parkinson’s Disease’ bringing together hundreds of scientists, clinicians and people with Parkinson’s to explore the latest Parkinson’s disease research. This research focused symposium will discuss the influence of…
The Anle138b Trial
This clinical trial is testing a small molecule called Anle138b to assess its potential to inhibit alpha-synuclein masses accumulating. In Parkinson’s, alpha-synuclein, which is abundant in nerve cells, begins clumping together (or aggregating) and it is believed that this process could be toxic. This trial, it is hoped, will slow-down…
Website focus group – can you help?
Our new website was designed to provide a clear message about who we are and why we are here. It has a straightforward design to help direct you to the most relevant information for your needs. But there’s still work to do…
NECTAR 2021
This event brings together scientists, clinicians, patient advocates and industry partners from across Europe and the international community to share the latest research in repairing the damage to the central nervous system as a result of degenerative diseases. Our Deputy Director of Research, Dr Simon…